| 标题 |
Twice-yearly depemokimab is well-tolerated in randomised, double-blind, placebo-controlled Phase III SWIFT and ANCHOR studies |
| 网址 | |
| DOI |
10.1183/13993003.congress-2025.pa2477
doi
|
| 其它 |
期刊:Airway pharmacology and treatment 作者:Marjolein Cornet; Arnaud Bourdin; Nicholas Bird; Dawn Edwards; Natalia Karkoszka; et al 出版日期:2025-09-27 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)